Introduction {#sec1-1}
============

Gastric cancer is the fourth most ordinary cancer worldwide and approximately two-thirds of all cases occur in developing countries. It is the fourth most common cancer in men, and the fifth most common in women. Despite a steady decline of its incidence in developed countries, in less developed countries such as those of the Middle and Eastern Asia, South America and Eastern Europe gastric cancer is an important burden on public health (Lee et al., 2013). Most of the northern and northwestern regions of Iran such as Ardabil, Semnan, Golestan, East Azerbaijan, and Tehran are at a high risk of gastric cancer, but the southern provinces show a lower level of incidence (Malekzadeh et al., 2009; Mansour-Ghanaei et al., 2012). It is a multi-factorial disease and develops because of a continuous cell damage caused by life-long exposure to different carcinogens. Environmental and behavioral factors including smoking, salt and salted food, diet, obesity, alcohol, radiation exposure, low socioeconomic status, and Helicobacter pylori infection are involved in the pathogenesis of gastric cancer. However, some people are at a high risk of gastric cancer (Kolahdoozan et al., 2010; Norouzinia et al., 2012). Adenocarcinomas, 90% of gastric tumors, subdivided into 2 histologic types: (i) well-differentiated and (ii) undifferentiated (Lin et al., 2007). In terms of genetics, a variety of genes such as MCC, APC, and p53 tumor suppressor genes increases the risk of gastric cancer, while a calcium-dependent adhesion molecule, E-cadherin, has been identified in a large percentage of gastric cancers (Zali et al., 2011; Kordi-Tamandani et al., 2014).

IL-6 is a pleiotropic cytokine that has significant roles in both acute and chronic inflammation and several effects on many immune and non-immune cell types. Macrophages and T-cells secrete this cytokine to stimulate an immune response. Its gene is located on the short arm of chromosome7 (Van der Poll et al., 1997). In various diseases such as inflammatory, autoimmune and malignant diseases, IL-6 has pathological roles (Kishimoto, 2010; Leech et al., 2013). Immunohistochemistry and in-situ hybridization have shown that IL-6 is highly expressed and is secreted from both gastricepithelial cells and inflammatory cells infiltrating the gastric mucosa in H. pylori infection (Furukawa et al., 1998; Kordi-Tamandani et al., 2014). There have been several reports examining IL-6 induction by H. pylori infection from nonepithelial cells (Gobert et al., 2004). This cytokine is involved in multiple signaling cascades such as NF-κB, STAT3, and HIF-1α. IL-6 is essentially required for the differentiation of Th17 cells (Wemmie et al., 2003). Acid-Sensing Ion Channels (ASICs) belong to the amiloride-sensitive cation channels that are expressed in the central and peripheral nervous systems. In human, the ASIC family comprises *ASIC1*, *ASIC2*, *ASIC3*, and *ASIC4* subunit channels. ASICs consist of 500 to 560 amino acids. ASICs are homo or heterotrimers of homologous subunits (Leonard et al., 2003; Lingueglia et al., 2013). These channels have two transmembrane chains, an extracellular domain with several conserved cysteines, and intracellular N and C termini. ASICs are permeable to Na+ and Ca2+ ions and an external pH variation activate these channels. A variety of tissues expresses ASICs. The coding gene for *ASIC1* is located on the long arm of chromosom12 (Gründer and Chen, 2010). IL-6 has a-174 G/C polymorphism in its promoter region and its gene is located on chromosome No. 7 (7p 15.3).

Materials and Methods {#sec1-2}
=====================

Samples {#sec2-1}
-------

This study was performed with 85 samples (20 females and 65 males) of paraffin-embedded tissues of gastric adenocarcinoma, procured from the pathology service of Alzahra Hospital in Isfahan, Iran, and 117 normal blood samples as healthy controls. The samples belonged to patients who underwent curative gastrectomy between 2009 and 2014. The control subjects comprised the margins of tumor site that were unaffected and pathologist confirmed them to be healthy. The demographic, pathological and clinical characterizations of participates were cited by Kordi et al., (2012).

Genomic DNA extraction {#sec2-2}
----------------------

Genomic DNA was extracted from the paraffin-embedded tissues using the phenol-chloroform DNA extraction method. Blood samples were collected in EDTA-coated tubes for DNA extraction and genotypic analysis, as previously described. For the DNA extraction, a Cinnapure DNA purification kit was used. Polymorphisms were identified by PCR using the Tetra Amplification Refractory Mutation System (T-ARMS), which is a simple and rapid detection method for different types of mutations. Amplification of *IL-6* and *ASIC1* genes was set according to the following PCR conditions: 10 µl premix master mix (including Taq, dNTP, Buffer, and Mg^2+^) 1 µl of each outer primer and 1.5 µl of each inner primer (10 mmol/l), and 3.5 µl of RNase-free double distilled water. The PCR was heated at 95°C for 10 min., followed by 40 cycles at 95°C for 30s, annealing at 54°C (*ASIC1* *rs75624685*), and 57°C (IL-6174) for 30 s, extension at 72°C for the 30 s, and the final extension by incubation at 72°C for 10 min.

Tetra-primer amplification refractory mutation system PCR (T-ARMS-PCR) {#sec2-3}
----------------------------------------------------------------------

The polymorphisms of the *ASIC1* (*rs75624685*) and IL-6 174 genes were genotyped employing the T-ARMS-PCR technique. The sequences of inner and outer primers are listed in [Table 1](#T1){ref-type="table"} in addition to PCR product sizes and annealing temperatures. The PCR products were evaluated by electrophoresis on a 2% agarose gel and visualized by ethidium bromide staining.

###### 

Primers Sequences and Annealing Temperatures

  Genes                                Seqences (5'-3')                     Product size (bp)   Annealing temp (°C)
  ------------------------------------ ------------------------------------ ------------------- ---------------------
  ASIC1                                F: ATGGAAAGTGCTACACGTTCAA            192                 60
  R: GTTCATCCTGACTATGGATCTGC                                                                    
  IL-6                                 F: ACTCACCTCTTCAGAACGAATTG           149                 60
  R: CCATCTTTGGAAGGTTCAGGTTG                                                                    
  RNA 18S                              F: GTAACCCGTTGAACCCCATT              112                 60
  R: CCATCCAATCGGTAGTAGCG                                                                       
  ASIC1 *rs75624685*                   Fo: CTACAGTTGGTCGCTCTTTCTCAAGTGAA    332                 54
  Ro: GAACCATTTAGGAGGAATGGTGATGATG                                                              
  Fi: TGTGCTAAGATAAAAACTAAAACATGTCTG   204 (G allele)                                           
  Ri: GCTGGCAGGTGCTGTGGAGTTGACAG       176 (C allele)                                           
  IL-6-174 G/C *rs1800795*             Fo: GACTTC AGCTTT ACTCTTTGTCAAGACA   326                 57
  Ro: GAATGAGCCTCAGACATCTCCAGTCCTA                                                              
  Fi: GCACTT TTCCCC CTAGTTGTGTCTTCCG   205 (G allele)                                           
  Ri: ATTGTGCAATGTGACGTCCTTTAGCTTG     184 (C allele)                                           

RNA extraction and RT-PCR {#sec2-4}
-------------------------

The isolation of total RNA from paraffin-embedded tissues was performed using Cinna pure RNA, cat.No.PR891620 (sinaclon.com) following the manufacturer's protocol. Subsequently, the first-strand cDNA was synthesized from 1-10μg of total RNA using a 2-step RT-PCR kit (vivantis, [www.vivantechnologies.com](http://www.vivantechnologies.com)) according to the supplier's protocol. Real-time PCR was performed with Applied Biosystem Real-Time PCR and in 16μl-reaction volume with Power SYBR Green PCR Master Mix (Applied Biosystem) under the following conditions: 1 cycle of 95°C for 10 min; 40 cycles of 95°C for 15 s, 60°C for 30 s, and 72°C for 40 s; finally, 1 cycle of 72°C 10 min. for extension, and 1 cycle of 60-95°C for the melting curve. The PCR products were tested gel in electrophoresis with 2% agarose and visualized with ethidium bromide staining. The primer sequences used for the expression study are listed in [Table 2](#T2){ref-type="table"}. The expression of *ASIC1* and *IL-6* were normalized by rRNA18s and was given by2^-∆∆CT^.

###### 

Comparison of Relative Gene Expression for ASIC1and IL-6 Genes between Cases and Controls

  Genes              No.          Mean±SD      P-value
  ---------- ------- ------------ ------------ ---------
  ASIC1      Cases   12           34.98±1.81   0.001
  Controls   12      31.23±2.62                
  IL-6       Cases   12           32.84±5.33   0.6
  Controls   12      32.47±2.62                

Statistical analysis {#sec2-5}
--------------------

SPSS version 20.0 (SPSS, Chicago, IL) and Epical Info were used for all statistical analyses. The significant P value was set at less than 0.05. Categorical data were analyzed by Pearson's x^2^.

Results {#sec1-3}
=======

No statistically significant differences were observed in the two genotypes *IL-6rs1800795G/C* promoter and *ASIC1rs75624685* between cases and controls (Figures [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}). The predominant genotype in both *IL-6rs1800795* and *ASIC1* r *s75624685* polymorphism was GG in the cases and the controls; also, the GC genotype was absent in both polymorphisms. The evaluated mRNA expression levels of *ASIC1* was remarkably different in patients and healthy controls (p\<0.001). We did not find any association between the expressions of IL-6 and gastric cancer (p=0.6) ([Table 2](#T2){ref-type="table"}).

![The Products of Tetra-ARMS PCR for ASIC1 (*rs75624685*). Control band 332bp and GG band 204bp.](APJCP-19-3451-g001){#F1}
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Discussion {#sec1-4}
==========

Interleukin (IL) genes are the most studied genes for gastric cancer (Gianfagna et al., 2008). All cancers are associated with inflammation for example, in gastric inflammation; epithelium starts cellular transformation and, by inducing immune responses and utilizing signaling cascades, contributes to invasion. Hallmarks of cancer such as DNA mutation, proliferation, angiogenesis, apoptosis, and invasion are related to inflammation. Through two intrinsic and extrinsic pathways, cancer and inflammation are connected, in extrinsic pathway, secreting chemokines, cytokines increase the risk of cancer, while genetic alterations such as activation of proto-oncogenes, inactivation of tumor suppressor genes, and instability of chromosomes are involved in the intrinsic pathway (Amjadi et al., 2014). Several studies reported that gastric carcinoma cells secrete many cytokines that play key roles in both cellular and immune responses (Ohta et al., 2003; Kai et al., 2005). Also, these authors showed that gastric cancer tissues contain high levels of the proinflammatory cytokines IL-1‚ and IL-6, and that the levels of these cytokines are associated with the tumor growth pattern (Takeda et al., 1991; Akira et al., 1993; Ueda et al., 1994). IL-6 activates the target genes involved in differentiation, survival, apoptosis, and proliferation. It also manipulates the process of tumorigenesis and the progression of the tumor (Weidle et al., 2010; Li et al., 2016). As mentioned above, the IL-6/IL-6R signal pathway promotes tumor growth, angiogenesis, invasion and migration in various cancers, such as epithelial ovarian cancer (Johnston et al., 2015). Studies by Lin et al., (2007) showed that the expression of IL-6 was related to the promotion of human gastric cancer invasion and migration of AGS cells. IL-6 signaling was exerted by the interaction of IL-6 with the gp130/IL6R complex in addition to by interaction of soluble IL6R/IL6 complex with gp130. The result of these interactions is JAK/STAT3 activation and MEK/ERK signaling, respectively (Weidle et al., 2010). In the tumor microenvironment, the production of IL-6 via HNSCC cells and stromal cells can activate STAT3 and contributes to tumor progression and drug resistance. Investigations by Chen et al., (2015) showed the effect of the vasoactive intestinal peptide on gastric cancer via tumor-associated macrophages by suppressing the expression levels of TNFα, IL-6, IL-12, and iNOS. VIP treatment significantly depressed TAM activation. In addition, TNFα, IL-6, IL-12 and iNOS expression in TAM were depressed with VIP treatment, and the VIP treated TAM depressed the gastric cancer cells. The presence of the C allele is associated with increased cancer risk and aggressive tumor behavior. In line with our results, a meta-analysis by Yin et al., (2012) showed that IL-6 gene-174C/G and-572C/G polymorphisms were not associated with the risk of gastric cancer. Our results also are consistent with the Gatti et al., (2007) findings; they did find any association between the frequencies of -174 SNP with the histological type of gastric adenocarcinoma, but the G allele at -174 was significantly higher in gastricadenocarcinoma than in patients with chronic gastritis. Shu et al., (2015) showed that compared to open gastrectomy (OG), laparoscopic-assisted gastrectomy (LAG) was associated with significantly lower serum levels of IL-6. Hence, LAG, among Asian populations, carries a markedly lower risk of adverse inflammatory reactions in GC patients. Investigation by Wang et al., (2012) showed that polymorphisms of IL-6-174 G/C, -572 G/C and -597 G/A were not associated with the risk of gastric cancer. In the present study, we focused on *ASIC1*, the most abundant ASIC subunit in the mammalian central nervous system (CNS). ASICs contribute to gastric acid hypersensitivity and pain under conditions of gastritis and peptic ulceration but also cause colonic hypersensitivity to mechanical stimuli (distension) under conditions of irritation that are not necessarily associated with overt inflammation. Investigation by Wong et al., (2008) on the Huntington disease showed that low-level of ASIC was impressiveness to the chance of a cure. Studies by Yifeng et al., (2011) show that a low-level expression of ASIC is related to the remedy of ischemic-brain attack. According to a report by Wu et al., (2014) high level of expression of ASIC is related to the progression of cancer. Previous studies had observed significant differences in the frequencies of IL-6 polymorphism in the−174 G/C loci in breast cancer, uterine leiomyosarcoma, and multiple myeloma. The result of Litovkin et al., (2007) in the distribution of this polymorphism in Ukrainian patients with breast cancers or uterine leiomyosarcoma compared with those in Macedonia, Italy, and Finland showed significant differences in the−174 G/C allele. Analysis of the G allele frequency by Duch et al., (2007) in patients with multiple myeloma revealed that its frequency in the Brazilian population was higher than in the European population. In addition, another study showed a lower frequency of the G allele in Taiwanese patients with CRC than Caucasian populations (Yeh et al., 2010). The genetic characteristic of this polymorphism may be different in diverse disease. Our findings indicate for the first time an association of the *ASIC1* gene expression with the risk of gastric cancer. Ultimately, we are suggesting a verification of the present data, conducting extensive studies with large sample sizes in various genetic populations.
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